Esophageal cancer natural history, complications and prognosis

	Esophageal cancer Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Differentiating Esophageal cancer from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X-ray
Echocardiography and Ultrasound
CT
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Esophageal cancer natural history, complications and prognosis On the Web
Most recent articles
cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Esophageal cancer natural history, complications and prognosis All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Esophageal cancer natural history, complications and prognosis
CDC on Esophageal cancer natural history, complications and prognosis
Esophageal cancer natural history, complications and prognosis in the news
Blogs on Esophageal cancer natural history, complications and prognosis
Directions to Hospitals Treating Esophageal cancer
Risk calculators and risk factors for Esophageal cancer natural history, complications and prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Natural History

Complications

Prognosis

5-Year Survival

Between 2004 and 2010, the 5 year relative survival of patients with esophageal cancer was 20 %.^[1]

When stratified by age, the 5 year relative survival of patients with esophageal cancer was 19.8 % and 15.5 % for patients <65 and ≥ 65 years of age respectively.^[1]

The survival of patients with esophageal cancer varies with the stage of the disease. Shown below is a table depicting the 5 year relative survival by the stage of esophageal cancer:^[1]

Stage	5 year relative survival (%), (Insert range of years here)
All stages	17.5%
Localized	39.6%
Regional	21.1%
Distant	3.8%
Unstaged	11.5%

Shown below is an image depicting 5 year conditional relative survival (probability of surviving in the next 5 years given the cohort has already survived 0, 1, 3 years) by stage at diagnosis according to SEER.^[1]

[Insert figure x.5 here]

References

↑ ^1.0 ^1.1 ^1.2 ^1.3 Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z,Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.

Template:WikiDoc Sources

[SEER-1] 1.0 ^1.1 ^1.2 ^1.3 Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z,Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.

[1]